Jasper Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Mahal Jeetinder Singh unloaded Company’s shares for reported $21740.0 on Jun 12 ’24. In the deal valued at $24.16 per share,900 shares were sold. As a result of this transaction, Mahal Jeetinder Singh now holds 25,009 shares worth roughly $0.57 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Mahal Jeetinder Singh sold 900 shares, generating $23,792 in total proceeds. Upon selling the shares at $26.44, the Chief Operating Officer now owns 25,009 shares.
Before that, Velan Capital Investment Manag bought 350,000 shares. Jasper Therapeutics Inc shares valued at $4,532,500 were divested by the 10% Owner at a price of $12.95 per share. As a result of the transaction, Velan Capital Investment Manag now holds 1,188,500 shares, worth roughly $26.98 million.
Stifel initiated its Jasper Therapeutics Inc [JSPR] rating to a Buy in a research note published on June 27, 2024; the price target was $86. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. Evercore ISI began covering JSPR with “an Outperform” recommendation on April 03, 2024. RBC Capital Mkts started covering the stock on March 28, 2024. It rated JSPR as “an Outperform”.
Price Performance Review of JSPR
On Friday, Jasper Therapeutics Inc [NASDAQ:JSPR] saw its stock jump 3.13% to $22.70. Over the last five days, the stock has gained 2.62%. Jasper Therapeutics Inc shares have risen nearly 187.71% since the year began. Nevertheless, the stocks have risen 68.15% over the past one year. While a 52-week high of $31.01 was reached on 04/01/24, a 52-week low of $4.00 was recorded on 01/02/24. SMA at 50 days reached $23.08, while 200 days put it at $15.57. A total of 1.61 million shares were traded, compared to the trading of 0.16 million shares in the previous session.
Levels Of Support And Resistance For JSPR Stock
The 24-hour chart illustrates a support level at 21.28, which if violated will result in even more drops to 19.87. On the upside, there is a resistance level at 23.80. A further resistance level may holdings at 24.91. The Relative Strength Index (RSI) on the 14-day chart is 47.15, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 42.93%. Stochastics%K at 42.46% indicates the stock is a holding.
The most recent change occurred on March 18, 2024 when TD Cowen began covering the stock and recommended ‘”an Outperform”‘ rating.
